Research institute advancing nanomedicine, tissue engineering, and bioengineering for clinical translation
IBEC is a public research institute in Barcelona conducting interdisciplinary work across nanomedicine, tissue engineering, biomaterials, and biomedical imaging. The tech stack—COMSOL, MATLAB, ANSYS, Python, R, plus specialized biomedical tools (DICOM, ImageJ, CRISPR-Cas9, 3D printing)—reflects a computationally-intensive, simulation-driven research operation. Active projects span drug delivery systems, organoid development for personalized medicine, and lentiviral vector optimization for cell therapy, grounded in solving specific clinical challenges (NAFLD modeling, antibiotic resistance, therapy evasion).
Founded in 2005 as a collaborative venture between the Catalan government and the University of Barcelona and Technical University of Catalonia, IBEC operates 22 research groups with 318 staff and researchers across 37 countries. The institute conducts fundamental and translational research at the intersection of engineering and life sciences, with particular focus on nanomedicine applications, tissue engineering scaffolds, microfluidic devices, and biocompatible nanomaterials for drug delivery. Located in the Parc Científic de Barcelona, IBEC works with both public and private sector partners to advance quantitative life sciences and bridge discovery toward clinical use.
IBEC conducts interdisciplinary research in nanomedicine, tissue engineering, biomaterials, biomedical imaging, and biotechnology. Current projects include organoid development for personalized medicine (NAFLD), enzyme-nanomotor systems, lentiviral vector manufacturing for CAR-T therapy, and nanocarrier drug delivery.
IBEC's stack emphasizes computational and biomedical tools: COMSOL, MATLAB, ANSYS, and Python for simulation; ImageJ and DICOM for biomedical imaging; CRISPR-Cas9 for genetic engineering; 3D printing for scaffold fabrication; and GitHub/GitLab for version control.
Other companies in the same industry, closest in size